Abstract
No public abstract is available from the verified source records.
Alva Bowen Weir, Mollie deShazo, Sandeep Samant, Arti Hurria
Abstract
Authors
Institutions
No local reference links have been materialized yet.
No local citing links have been materialized yet.
Global cancer statistics
2011
Chapter 2: cancers of the head and neck in cancer survival among adults: U.S. SEER Program, 1988–2001
2007
A practical approach to Geriatric assessment in oncology
10.1200/jco.2006.10.2954 · 2007
How does older age influence an oncologists' cancer management
10.1634/theoncologist.2009-0198 · 2010
Importance of functional measures in predicting mortality among older hospitalized patients
10.1001/jama.279.15.1187 · 1998
Development and validation of a prognostic index for 4 year mortality in older adults
10.1001/jama.295.7.801 · 2006
Cancer screening in elderly patients
10.1001/jama.285.21.2750 · 2001
Comprehensive geriatric assessment for older patients with cancer
10.1200/jco.2007.10.6559 · 2007
The vulnerable elders survey: a tool for identifying vulnerable older people in the community
10.1046/j.1532-5415.2001.49281.x · 2001
Detecting disabilities in older patients with cancer; comparison between comprehensive geriatric assessment and Vulnerable Elders Survey — 13
Provenance
crossref
Confidence 100%
ror
Confidence 99%
ror
Confidence 99%
ror
Confidence 99%
openalex
Confidence 95%
unpaywall
Confidence 95%
datacite
Confidence 0%
10.1200/jco.2009.25.9978 · 2010
Validation of a screening tool for elderly patients in oncology. ASCO Annual Meeting Abstracts
10.1200/jco.2008.26.15_suppl.20568 · 2008
Can the vulnerable elders survey — 13 and/or the G8 adequately identify elderly patients with head and neck cancer in need of comprehensive geriatric assessment?
10.1200/jco.2011.29.15_suppl.e19670 · 2011
Pre-operative assessment of cancer in the elderly (PACE): a comprehensive assessment of underlying characteristics of elderly cancer patients prior to elective surgery
10.1016/j.suronc.2007.04.009 · 2006
Shall we operate? Preoperative assessment in elderly cancer patients. (PACE) can help: an SIOG surgical task force prospective study
10.1016/j.critrevonc.2007.11.001 · 2008
Predicting chemotherapy toxicity in older adults with cancer: a prospective multicenter study
10.1200/jco.2011.34.7625 · 2011
The chemotherapy risk assessment scale for high-age patients (CRASH) score: design and validation. ASCO meeting abstracts
10.1200/jco.2010.28.15_suppl.9000 · 2010
Surgical outcomes for patients aged 80 and older: morbidity and mortality from major noncardiac surgery
10.1111/j.1532-5415.2005.53159.x · 2005
Age as a prognostic factor for complications of major head and neck surgery
10.1001/archotol.131.7.605 · 2005
Predictive factors for complications in elderly patients who underwent head and neck oncologic surgery
10.1002/hed.20671 · 2008
Microvascular free tissue transfer in elderly patients: the Toronto experience
10.1002/hed.10240 · 2003
Age as a prognostic factor for head and neck squamous cell carcinoma: should older patients be treated differently?
10.2310/7070.2005.4076 · 2006
Should older head and neck patients be treated differently?
10.1016/j.anorl.2010.12.009 · 2011
Head and neck cancer surgery in the elderly — does age influence the postoperative course?
10.1016/j.oraloncology.2009.10.002 · 2010
Head and neck squamous cell carcinoma in elderly patients: a long-term retrospective review of 273 cases
10.1001/archotol.127.9.1089 · 2001
Quality of life in elderly patients with head and neck cancer one year after diagnosis
10.1002/hed.20113 · 2004
Cancer-directed surgery for localized disease: decreased use in the elderly
10.1245/aso.2004.03.052 · 2004
No age limit for radical radiotherapy in head and neck tumors
10.1016/s0959-8049(96)00265-1 · 1996
Radiotherapy in head and neck cancer in the elderly: a challenge
10.1016/s1040-8428(00)00061-5 · 2000
Head and neck cancer in the elderly: an overview of treatment modalities
10.1016/j.ctrv.2008.11.002 · 2009
Patterns of care in elderly head and neck cancer radiation oncology patients: a single cohort study
10.1016/j.ijrobp.2009.10.052 · 2011
Meta analysis of radiotherapy in carcinoma of the head and neck
10.1097/cco.0b013e3280f01010 · 2007
Cerebrovascular disease risk in older head and neck cancer patients after radiotherapy
10.1200/jco.2008.16.6546 · 2008
Meta-analysis of chemotherapy in head and neck cancer (MACH-NC): an update on 93 randomised trials and 17,346 patients
2009
Factors associated with severe late toxicity after concurrent chemoradiation for locally advanced head and neck cancer: an RTOG analysis
10.1200/jco.2007.14.8841 · 2008
Concurrent chemotherapy and radiotherapy for organ preservation in advanced laryngeal cancer
10.1056/nejmoa031317 · 2003
Preliminary results of Radiation Therapy Oncology Group 97–03: a randomized phase II trial of concurrent radiation and chemotherapy for advanced squamous cell carcinoma of the head and neck
10.1200/jco.2004.12.012 · 2004
EGFR antagonists in cancer treatment
10.1056/nejmra0707704 · 2008
10.1200/jco.2006.06.7447
10.1200/jco.2006.06.7447 · 2007
Radiotherapy plus cetuximab for locoregionally advanced head and neck cancer: 5-year survival data from a phase 3 randomized trial, and relation between cetuximab induced rash and survival
10.1016/s1470-2045(09)70311-0 · 2010
Cisplatin, fluorouracil and docetaxel in unresectable head and neck cancer
10.1056/nejmoa071028 · 2007
The development of clinical practice guidelines and guidance statements of the American College of Physicians: summary of methods
10.7326/0003-4819-153-3-201008030-00010 · doi-reference
Treatment of head and neck cancer in the elderly
10.1007/s00405-010-1263-6 · doi-reference
Population based study of competing mortality in head and neck cancer
10.1200/jco.2011.35.7301 · doi-reference
A matched survival analysis for squamous cell carcinoma of the head and neck in the elderly
10.1097/00005537-200302000-00030 · doi-reference
Head and neck squamous cell carcinoma in patients aged ≥ 80
10.1002/cncr.23931 · doi-reference
Platinum based chemotherapy plus cetuximab in head and neck cancer
10.1056/nejmoa0802656 · doi-reference
Outcome of elderly patients with recurrent or metastatic head and neck cancer treated with cisplatin-based chemotherapy
10.1200/jco.2004.08.039 · doi-reference
Defining risk levels in locally advanced head and neck cancers: a comparative analysis of concurrent postoperative radiation plus chemotherapy trials of the EORTC (#22931) and RTOG (#9501)
10.1002/hed.20279 · doi-reference
Postoperative concurrent radiotherapy and chemotherapy for high-risk squamous-cell carcinoma of the head and neck
10.1056/nejmoa032646 · doi-reference
Postoperative irradiation with or without concomitant chemotherapy for locally advanced head and neck cancer
10.1056/nejmoa032641 · doi-reference
Cisplatin and fluorouracil alone or with docetaxel in head and neck cancer
10.1056/nejmoa070956 · doi-reference